Ongoing evaluation of our results shows that we are able to cure 96.5% of patients with low-risk prostate carcinoma, of which 99% of patients do not experience any difficulties with incontinence.
Proton therapy is a precise and gentle treatment method for prostate cancer with minimal side effects.
Since 2012, when the PTC opened, we have treated thousands of patients with prostate cancer. Based on their long-term follow-up, the Prague Proton Center can report excellent results and successes in proton radiotherapy, ranking among the 5 best proton centres in the world.
Proton therapy at PTC is provided on an outpatient basis. Proton therapy at PTC takes 5, 19 or 21 working days, depending on the stage at which you were diagnosed.
Incontinence is an involuntary leakage of a small amount of urine, which causes a social and hygiene problem for patients and their caregivers.
In the case of proton therapy, the risk of incontinence is minimised to only 1% (for a disease detected at an early stage).
While, for example, after surgery (complete removal of the prostate) up to 15% of patients suffer from spontaneous leakage of urine, and with conventional radiation, this complication occurs in 5% of patients.
Very low risk of impotence (erectile dysfunction) owing to the precision of the proton beam compared to other methods of prostate cancer treatment, especially surgery.
After surgery, 30 to 100% of men experience a complete loss of erection (erectile dysfunction). From a psychological aspect, this enormously high risk represents a major complication for any man, and has a significant impact on his future life. Intervention near the nerves, damage to which causes erectile dysfunction, represents the risk factor in surgery.
Although erectile dysfunction affects a large percentage of patients after radical prostatectomy, and every patient should be informed about this risk in advance, surgery is often recommended for young, active men who are in excellent physical condition. According to the available data, there is no significant difference between laparoscopic and robotic surgery.
Only a small percentage of patients recover their sexual functions and the ability to ejaculate after surgery, which can subsequently be a problem from a reproductive point of view, when the man will not be able to father a child naturally.
Based on the results of the Prague Proton Center, recurrence of the disease is reported in only 3.5% of patients after proton therapy (in low-risk prostate cancers).
While after surgery, the disease recurs in 51 to 69% of patients (depending on the type of surgery).
A study published in European Urology in 2021 provides detailed information on prostate cancer recurrence rates after robotic surgery and open surgery. The study reported that 51% of patients had disease recurrence within 10 years after robotic surgery, and 69% of patients after open surgery.
And further, a study published in the Journal of Urology on 11 July 2016 provides more detailed information on prostate cancer recurrence rates after surgery. The study reports that:
